Works by Chan, Cheng-Wei


Results: 5
    1
    2
    3
    4

    Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study.

    Published in:
    Cardiovascular Diabetology, 2018, v. 17, p. 1, doi. 10.1186/s12933-018-0663-6
    By:
    • Chan, Cheng-Wei;
    • Yu, Chu-Leng;
    • Lin, Jiunn-Cherng;
    • Hsieh, Yu-Cheng;
    • Lin, Che-Chen;
    • Hung, Chen-Ying;
    • Li, Cheng-Hung;
    • Liao, Ying-Chieh;
    • Lo, Chu-Pin;
    • Huang, Jin-Long;
    • Lin, Ching-Heng;
    • Wu, Tsu-Juey
    Publication type:
    Article
    5